Literature DB >> 21747315

Long-period pancreatic stenting for painful chronic calcified pancreatitis required higher medical costs and frequent hospitalizations compared with surgery.

Morihisa Hirota1, Tohru Asakura, Atsushi Kanno, Kazuhiro Kikuta, Kiyoshi Kume, Shin Hamada, Jun Unno, Hiromichi Ito, Hiroyuki Ariga, Atsushi Masamune, Kennichi Satoh, Fuyuhiko Motoi, Shinichi Egawa, Michiaki Unno, Tooru Shimosegawa.   

Abstract

OBJECTIVES: The aim of this study was to compare the benefits between endoscopic drainage and surgical drainage of the pancreatic duct for patients with chronic calcified pancreatitis.
METHODS: A total of 68 patients were classified into endoscopic (n = 34) or surgical (n = 34) treatment groups. Patients receiving endoscopic treatment were further divided into 2 subgroups: a short-period group, patients who could discontinue serial pancreatic stenting within 1 year (n = 19); and a long-period group, patients who needed pancreatic drainage by serial endoscopic stenting for more than 1 year (n = 15). The medical records of these patients were retrospectively analyzed.
RESULTS: Hospital stays, frequency of hospitalizations, and medical expense were similar between the short-period endoscopic treatment group and surgery group. On the other hand, patients in the long-period endoscopic treatment group required significantly longer hospital stays, more frequent hospitalizations, and had higher medical expenses than the short-period endoscopic treatment group as well as than the surgery group.
CONCLUSIONS: Patients who underwent serial endoscopic stenting for more than 1 year showed no benefit compared with surgical treatment in terms of the frequency of hospital stays and medical costs.

Entities:  

Mesh:

Year:  2011        PMID: 21747315     DOI: 10.1097/MPA.0b013e31821a9215

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

Review 1.  Chronic pancreatitis in India and Asia.

Authors:  Pramod Kumar Garg
Journal:  Curr Gastroenterol Rep       Date:  2012-04

2.  Chronic fibrous-degenerative pancreatitis with involvement of adjacent organs and their dysfunction: contemporary approaches to surgical treatment.

Authors:  Volodymyr Ivanovych Pylypchuk; Marco Vito Marino; Andriy Yavorskyy
Journal:  Transl Gastroenterol Hepatol       Date:  2016-06-06

3.  Is endoscopic therapy the treatment of choice in all patients with chronic pancreatitis?

Authors:  Beata Jabłońska
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

4.  Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report.

Authors:  Müjde Soytürk; Göksel Bengi; Dilek Oğuz; İsmail Hakkı Kalkan; Mehmet Yalnız; Mustafa Tahtacı; Kadir Demir; Elmas Kasap; Nevin Oruç; Nalan Gülşen Ünal; Orhan Sezgin; Osman Özdoğan; Engin Altıntaş; Serkan Yaraş; Erkan Parlak; Aydın Şeref Köksal; Murat Saruç; Hakan Ünal; Belkıs Ünsal; Süleyman Günay; Deniz Duman; Alper Yurçi; Sabite Kacar; Levent Filik
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.555

5.  Prognostic factors of response to endoscopic treatment in painful chronic pancreatitis.

Authors:  Alina Tantau; Alina Mandrutiu; Daniel-Corneliu Leucuta; Lidia Ciobanu; Marcel Tantau
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

6.  Trial-based cost-effectiveness analysis comparing surgical and endoscopic drainage in patients with obstructive chronic pancreatitis.

Authors:  Philippe Laramée; David Wonderling; Djuna L Cahen; Marcel G Dijkgraaf; Dirk J Gouma; Marco J Bruno; Stephen P Pereira
Journal:  BMJ Open       Date:  2013-09-23       Impact factor: 2.692

Review 7.  Endoscopic treatment of pancreatic calculi.

Authors:  Yong Hoon Kim; Sung Ill Jang; Kwangwon Rhee; Dong Ki Lee
Journal:  Clin Endosc       Date:  2014-05-31

8.  Cost-effectiveness of benign Wirsung duct strictures treatment in chronic pancreatitis.

Authors:  Dariusz Łaski; Stanisław Hać; Iwona Marek; Jarosław Kobiela; Justyna Kostro; Krystian Adrych; Zbigniew Śledziński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-01-04       Impact factor: 1.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.